Financials data is unavailable for this security.
View more
Year on year Maravai LifeSciences Holdings Inc 's revenues fell -67.28% from 883.00m to 288.95m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 220.21m to a loss of 119.03m.
| Gross margin | 46.73% |
|---|---|
| Net profit margin | -58.24% |
| Operating margin | -18.29% |
| Return on assets | -8.74% |
|---|---|
| Return on equity | -27.59% |
| Return on investment | -11.38% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Maravai LifeSciences Holdings Inc fell by 57.18m. However, the company earned 126.22m from its operations for a Cash Flow Margin of 43.68%. In addition the company used 122.31m on investing activities and also paid 61.09m in financing cash flows.
| Cash flow per share | -0.8746 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.73 |
|---|---|
| Tangible book value per share | -0.3821 |
More ▼
Balance sheet in USDView more
| Current ratio | 10.00 |
|---|---|
| Quick ratio | 9.28 |
| Total debt/total equity | 1.27 |
|---|---|
| Total debt/total capital | 0.4167 |
More ▼
